Clinical Trials Browser

OTHER_GOV × Nasopharyngeal Carcinoma × nimotuzumab × Clear all

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence